Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JHPCY OTCQB) stock market data APIs
$12.175
0(0%)
as of October 15, 2026
Try our APIs with
free plan!
Jiangsu Hengrui Pharmaceuticals Co.,Ltd Financial Data Overview
Price chart is built with
Anychart
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Prev. Close
12.175
Open
12.175
High
12.175
Low
12.175
52 wk Range
11.5-20
Market Cap
41 482 M
P/E Ratio
37.8788
Shares Outstanding
129 M
Revenue
32 564 M
EPS
0.0972
Beta
0.041
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd data using free add-ons & libraries
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd Fundamental Data
Jiangsu Hengrui Pharmaceuticals Co.,Ltd Fundamental data includes:
- Net Revenue: 32 564 M
- EBITDA: 9 453 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-06-30
- EPS/Forecast: NaN
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Jiangsu Hengrui Pharmaceuticals Co.,Ltd News
New
Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus
Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and ...
Novo Nordisk strikes $2.6B obesity drug deal with China's Hengrui
[Novo Nordisk sign on building, Danish pharmaceutical healthcare giant, production innovative drugs, obesity treatment Ozempic, pharmaceutical company innovation, Mainz, Germany June 15, 2024] Victor ...
Heart drug developer Braveheart Bio surges on public debut after upsized IPO
[IPO Initial Public Offering on Financial Stock Market Chart 3D render] gonin Braveheart Bio (BRVE [https://seekingalpha.com/symbol/BRVE]), a clinical-stage drug developer focused on cardiovascular d...
Kailera falls after late-stage trial data for oral GLP-1 candidate
[Red dollar sign pointing down with arrow, concept of financial loss, market decline and recession, 3d render] Shares of Kailera Therapeutics (KLRA [https://seekingalpha.com/symbol/KLRA]) slipped mor...
Get Jiangsu Hengrui Pharmaceuticals Co.,Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.